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   A 2-month-old girl having a left multicystic dysplastic kidney with contralateral mild hydrone-
phrosis is described. Furosemide was administered orally because of hyperpotassemia during the 
period between 1 month and 7 months of age. Peripheral plasma renin activity and plasma aldo-
sterone activity increased at the age of 6 months, and ultimately reached the peak at 9 days after 
discontinuation of furosemide at the age of 7 months, Peripheral plasma renin activity and 
plasma aldosterone activity were normalized at the age of 11 months. Blood pressure during the 
whole period was normal. Contralateral hydronephrosis was improved gradually. The level of 
serum creatinine became normal at the age of 50 days. 
   A case with a high level of plasma renin and aldosterone activity temporarily induced by 
furosemide was reported. Pathophysiology of pseudo-Bartter syndrome without hypopotassemia due 
to furosemide is discussed. 
                                                    (Acta Urol. Jpn.  41: 51-55, 1995) 


















































































































































血液生化学検査で水腎症の増悪は認 め られず,生 後
3ヵ月目に血清クレアチニソ値はo.2mg/dlに下降


































ンが89ng/dlと高値を指摘 された.血 圧 は正常 で
あったが,再検査 した ところ血漿 レニソ10.5ng/m正
perhour(正常値 は年齢別平均+標準偏差×2を図
中に示 した10)),アル ドステロン76ng/d1(同上)と
高値を示 した(Fig.2),フロセ ミド投与 との関係で
は,そ の投与中から血漿 レニンとアル ドステロソは高
値を示 し,フロセミド投与中止後にアル ドステロソが

































してバーター症候群 が考え られ る.バ ーター症候群
は,1962年にBartterらによって発見された疾患で,
血漿 レニン活性 お よび血漿アル ドステロン濃度 の増
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